#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Herpes simplex Hereditary optic atrophy Chronic granulomatous disease Dermatomyositis Arteriovenous malformation Acute graft versus host disease in skin Transitional cell carcinoma Thalassaemia beta Angiosarcoma Bulbospinal muscular atrophy congenital Hypoparathyroidism Extraskeletal ossification Cystic fibrosis lung Pleural mesothelioma Autoimmune haemolytic anaemia More trials…
Learn about Rare Diseases

Glycogen storage disease type I – Treatment Lymphatic malformation Waldenstrom’s macroglobulinaemia refractory Langerhans’ cell histiocytosis – Treatment Langerhans’ cell histiocytosis – Trials in Disease Chordoma Atypical haemolytic uraemic syndrome – Treatment Encephalitis autoimmune – Basic Information Marginal zone lymphoma – Life with Disease Niemann-Pick disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Selpercatinib ACARBOSE Iloprost Trometamol Mitazalimab Iph6501 Ezabenlimab Human Albumin Solution Panitumumab Ozanimod Ublituximab Indometacin Ph. Eur. Regn7508 Pegunigalsidase Alfa Elacestrant Betamethasone Sodium Phosphate Ribociclib GSK5460025A Vutrisiran BUDOPRUTUG Berotralstat More therapies…

Learn about Your Condition

Uterine leiomyosarcoma Juvenile spondyloarthritis Diabetic foot Triple negative breast cancer Tendon injury Ependymoma Hypothyroidism Thalassaemia alpha Pancoast's tumour Procedural anxiety Sarcoma metastatic Low cardiac output syndrome BK virus infection Obesity Urinary incontinence More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Paraganglion neoplasm

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

Recruiting

3 1 1
Investigated Drugs:
- Belzutifan
- Lenvatinib
+4
Study on Using Exenatide PET/CT Imaging for Detecting Paragangliomas in Patients

Recruiting

2 1 1 1
Investigated Diseases:
- Paraganglion neoplasm
Investigated Drugs:
- Exenatide
Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

Not yet recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Lutetium (177Lu) Edotreotide
Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Paraganglion neoplasm

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

Study on Using Exenatide PET/CT Imaging for Detecting Paragangliomas in Patients

Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies